Study links COVID-19 and some vaccines to increased risk of rare neurological condition
June 2025
UK Study Reveals Long-Term Safety of COVID-19 Vaccine
May 2025
The Drug Safety Research Unit has announced Linda Härmark as its new Director.
April 2025
DSRU appoints Linda Härmark as director
March 2025
Drug Safety Research Unit announces new director
March 2025
Alzheimer’s drug requires strengthened pharmacovigilance approach
March 2025
Revised additional risk minimisation guidelines – change for the better
December 2024
The approval of lecanemab – a pharmacovigilance perspective
November 2024
Real World Safety Studies
November 2024
Changing Faces May-June 2024: Government, non-profit, and professional organisation
August 2024
Move of the month Dr Alison Evans appointed head of education and training at Drug Safety Research Unit
August 2024
The Drug Safety Research Unit (DSRU) has announced Dr Alison Evans as its new Head of Education and Training.
August 2024
Resignation of DSRU director triggers search for successor
July 2024
Director of the Drug Safety Research Unit to step down next year
July 2024
30 years at the forefront of pharmacovigilance – Saad Shakir’s remarkable journey
July 2024
Health Industry Leaders Issue 04
June 2024
Evidence use for product withdrawal is leaning toward observational research
March 2024
The eliminator – Evidence use for product withdrawal is leaning toward observational research
March 2024
The Therapy Suite
December 2023
Understanding the evidence used in drug product withdrawals
December 2023
Understanding the evidence used in drug product withdrawals
December 2023
Southampton scientist internationally recognized through award win
December 2023
Laboratory News – Online surveys key to safety data for novel vaccines concludes report
May 2023
New Medical – Web-based surveys offer a feasible way to monitor the safety of novel vaccines
May 2023
PharmaTimes – Three years on, how did the pandemic transform pharmacovigilance?
May 2023
BMJ – Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients
October 2022
Pink Sheet – Evusheld: UK urged to use RWD to give clinically vulnerable early access to COVID-19 treatment
September 2022
European Pharmaceutical Review – How can evidence-based medicine (EBM) methodology support drug withdrawals
July 2022
Pharmafocus – Key trends for UK drug safety in 2022
January 2022
News Medical – Heart inflammation more common among men following mRNA-based COVID-19 vaccination
September 2021
EPM magazine – The MedTalk Podcast – Understanding Covid-19 vaccines with the DSRU
August 2021
EPM magazine – Flu vaccine monitoring in the UK to include teenagers for the first time
August 2021
Pharma Jobs – DSRU says more research needed to understand immunocompromised patients’ responses to Covid-19 vaccines
July 2021
Pharmatimes – DSRU says more research needed to understand immunocompromised patients’ responses to Covid-19 vaccines
July 2021
Pink Sheet: Vaccine study kicks off in the UK (2/7/21 Covid notebook – subscription required)
July 2021
Guardian: Windmills of your mind: viral Covid jab ‘hack’ placebo effect at best, say doctors
June 2021
PharmaTimes – Safety first
May 2021
Guardian – Keep taking AstraZeneca jab, says PM, as trial paused to investigate clot reports (7/4/21 p6/7)
April 2021
Pharmacy Business – Pharmacists urged to promote Oxford vaccine safety study among patients
April 2021
Scrip – Regulators reassure on AZ vaccine safety after rare side effects deemed plausible
April 2021
Financial Review – European, UK experts turn up pressure on AstraZeneca over blood clots
April 2021
Nature – Covid vaccines and blood clots: Five key questions
April 2021
European Pharmaceutical Review – US pauses administration of Janssen Covid-19 vaccine
April 2021
Pharmacy Business – Pharmacists urged to promote Oxford vaccine safety study among patients
April 2021
European Pharmaceutical Review – Global pharmacovigilance observatory to aid pharma’s understanding of regulatory decisions
April 2021
PharmaTimes – Benefits of AZ vaccine outweigh risks, say MHRA
April 2021
Guardian – AstraZeneca jab worry may play into the hands of anti-vaxxers, say Tories Also covered by Yahoo and MSN
April 2021
Guardian – Wednesday briefing: Keep getting jab, Johnson urges
April 2021
MSN – Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts
April 2021
Guardian – Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts
April 2021
FT – Blood clots and the AstraZeneca Covid vaccine:
April 2021
Daily Mail – Why are drugs for the old tested on the young?
March 2021
The BMJ – Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance
March 2021
https://www.dailymail.co.uk/health/article-9339743/Why-drugs-old-tested-young.html
March 2021
European Pharmaceutical Manufacturer – Oxford/AstraZeneca Covid-19 vaccine should continue to be used, UK researchers say
March 2021
Pharmacy Business – Pharmacists urged to participate in Oxford vaccine safety study
March 2021
Guardian – Politics Live blog updating on a range of Covid-19 developments
March 2021
European Pharmaceutical Manufacturer – Post market study of Oxford Covid-19 vaccine begins
February 2021
Portsmouth News – Portsmouth associate drug safety unit to study side effects of COVID-19 vaccine
February 2021
Nursing Times – Call for nurses to join Covid-19 vaccine side effects study
February 2021
South Wales Argus – Oxford/AstraZeneca vaccine safety study – Wales recruits needed
February 2021
Southampton Echo – Southampton drug safety unit to start study of COVID-19 vaccine
February 2021
Reuters UK – What you need to know about coronavirus right now
December 2020
Newsbreak.com – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
County Press (Isle of Wight) – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
The National (Scotland) – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
Thisislocallondon – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
AOL – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
MSN – New vaccine will be monitored long term to ‘build body of knowledge’
December 2020
PharmaTimes – DSRU plans post-authorisation study of Covid-19 vaccines in the UK
December 2020
PharmaTimes – The Covid vaccines safety net
December 2020
European Pharmaceutical Review – Drug Safety Research Unit says repurposed drugs for Covid-19 still require a lot of testing
November 2020
European Pharmaceutical Manufacturer – Re-purposed drugs for Covid-19 need rigorous testing
November 2020
Pink Sheet (30/11/20) – Coronavirus Notepad: Repurposed drugs need thorough testing (link for subscribers)
November 2020
European Pharmaceutical Manufacturer – UK research unit stresses need for monitoring of newly licensed Covid-19 vaccines
November 2020
Pink Sheet (16/11/20) – EU mandates monthly safety summaries for approved Covid-19 vaccines (DSRU comments on the need for robust post-authorisation safety studies)
November 2020
Pharmafocus – Opportunities and challenges for re-purposing drugs for Covid-19 (p12, Nov edition)
November 2020
Pharmafile – Remdesivir has favourable benefit-risk profile in Covid-19 but more data needed, DSRU review argues
October 2020
Pharmatimes.co.uk – Systematic benefit-risk study deems remdesivir a favourable Covid-19 treatment
October 2020
Pink Sheet – Coronavirus Notebook: Convalescent Plasma – Will It Recover From Setbacks?
September 2020
The Scientist – Scientists voice concerns over Russian COVID-19 vaccine
September 2020
Chemistry World – Russian Covid-19 vaccine data raises questions
September 2020
BMJ – Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma. Summary of DSRU’s benefit risk research included.
September 2020
Pink Sheet – Coronavirus Notebook: Convalescent Plasma – Will It Recover From Setbacks?
August 2020
BMJ – Covid-19: US FDA fires spokesperson over misleading claims about convalescent plasma. Summary of DSRU’s benefit risk research included.
August 2020
Pink Sheet: Coronavirus Notebook – Post Authorization Studies. DSRU’s ‘One Million’ study to monitor COVID-19 vaccines was mentioned in Pink Sheet’s weekly round-up(18/8/20)
August 2020
European Pharmaceutical Review – COVID-19 vaccines to be monitored post marketing by consortium in the UK
August 2020
European Pharmaceutical Manufacturer – Post-market study to monitor safety and effectiveness of COVID-19 vaccines
August 2020
Pharmafield – One Million study to monitor COVID-19 vaccine safety and effectiveness
August 2020
Pharmafield – No clear benefit of HIV antivirals for COVID-19 patients says study
July 2020
Pink Sheet – Coronavirus Notebook
July 2020
European Pharmaceutical Review – Consortium established to monitor COVID-19 vaccines after marketing
June 2020
PharmaTimes – New consortium will monitor safety/efficacy of COVID-19 vaccines
June 2020
The Courier – Dundee and St Andrews universities spearheading Covid-19 vaccine studies
June 2020
Pharmaceutical Technology – UK researchers form consortium to monitor Covid-19 vaccines
June 2020
European Pharmaceutical Manufacturer – Consortium formed to assess safety of Covid-19 vaccines
June 2020
Pharmafield – New consortium to monitor safety and effectiveness of Covid-19 vaccines
June 2020
Pharmafile – New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market
June 2020
Pink Sheet – New Consortium To Monitor Whether COVID-19 Vaccines Work As They Should
June 2020
PharmaTimes – PharmaTimes talks to Professor Saad Shakir
May 2020